Legal & General Group
VCYT icon

Legal & General Group’s Veracyte VCYT Stock Holding History

Legal & General Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.9M Buy
897,171
+206,414
+30% +$7.64M 0.01% 723
2025
Q4 		$29.1M Sell
690,757
-94,696
-12% -$3.82M 0.01% 733
2025
Q3 		$27M Buy
785,453
+204,271
+35% +$5.86M 0.01% 766
2025
Q2 		$15.7M Buy
581,182
+135,440
+30% +$3.92M ﹤0.01% 956
2025
Q1 		$13.2M Buy
445,742
+70,243
+19% +$2.68M ﹤0.01% 994
2024
Q4 		$14.9M Sell
375,499
-77,711
-17% -$2.94M ﹤0.01% 945
2024
Q3 		$15.4M Sell
453,210
-153,605
-25% -$4.32M ﹤0.01% 947
2024
Q2 		$13.1M Buy
606,815
+75,880
+14% +$1.6M ﹤0.01% 986
2024
Q1 		$11.8M Buy
530,935
+157,748
+42% +$3.85M ﹤0.01% 1055
2023
Q4 		$10.3M Buy
373,187
+49,027
+15% +$1.18M ﹤0.01% 1129
2023
Q3 		$7.24M Buy
324,160
+4,867
+2% +$125K ﹤0.01% 1237
2023
Q2 		$8.13M Buy
319,293
+23,469
+8% +$569K ﹤0.01% 1196
2023
Q1 		$6.6M Buy
295,824
+62,543
+27% +$1.51M ﹤0.01% 1278
2022
Q4 		$5.54M Sell
233,281
-72,927
-24% -$1.69M ﹤0.01% 1352
2022
Q3 		$5.08M Sell
306,208
-65,917
-18% -$1.48M ﹤0.01% 1361
2022
Q2 		$7.41M Buy
372,125
+74,329
+25% +$1.5M ﹤0.01% 1227
2022
Q1 		$8.21M Buy
297,796
+36,363
+14% +$1.04M ﹤0.01% 1253
2021
Q4 		$10.8M Buy
261,433
+48,996
+23% +$2.16M ﹤0.01% 1170
2021
Q3 		$9.87M Sell
212,437
-21,361
-9% -$932K ﹤0.01% 1187
2021
Q2 		$9.35M Buy
233,798
+93,344
+66% +$3.99M ﹤0.01% 1197
2021
Q1 		$7.55M Buy
140,454
+63,332
+82% +$3.65M ﹤0.01% 1378
2020
Q4 		$3.77M Sell
77,122
-12,206
-14% -$566K ﹤0.01% 1611
2020
Q3 		$2.9M Buy
89,328
+16,343
+22% +$519K ﹤0.01% 1600
2020
Q2 		$1.89M Buy
72,985
+50,802
+229% +$1.27M ﹤0.01% 1754
2020
Q1 		$568K Buy
22,183
+7,716
+53% +$194K ﹤0.01% 2033
2019
Q4 		$404K Buy
14,467
+4,316
+43% +$112K ﹤0.01% 2261
2019
Q3 		$241K Buy
10,151
+254
+3% +$6.76K ﹤0.01% 2314
2019
Q2 		$282K Buy
9,897
+5,273
+114% +$132K ﹤0.01% 2265
2019
Q1 		$116K Hold
4,624
– – ﹤0.01% 2448
2018
Q4 		$58K Buy
4,624
+518
+13% +$6.13K ﹤0.01% 2640
2018
Q3 		$39K Hold
4,106
– – ﹤0.01% 2900
2018
Q2 		$38K Sell
4,106
-747
-15% -$5.25K ﹤0.01% 2897
2018
Q1 		$27K Hold
4,853
– – ﹤0.01% 3032
2017
Q4 		$32K Buy
4,853
+1,393
+40% +$10.4K ﹤0.01% 3037
2017
Q3 		$30K Hold
3,460
– – ﹤0.01% 3061
2017
Q2 		$29K Buy
3,460
+1,562
+82% +$12.7K ﹤0.01% 3050
2017
Q1 		$17K Hold
1,898
– – ﹤0.01% 3118
2016
Q4 		$15K Buy
+1,898
New +$14.2K ﹤0.01% 3166

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Legal & General Group's VCYT Position: Q1 2026 in Review

Legal & General Group increased its Veracyte (VCYT) stake by 30% in Q1 2026, buying an estimated $7.64M and bringing the position to 897,171 shares worth $28.9M. The position accounts for 0.01% of the portfolio, ranked #723.

Legal & General Group first reported a position in VCYT in Q4 2016 and has held it in 38 quarters since. The position peaked at $29.1M in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Legal & General Group held 897,171 shares of Veracyte worth $28.9M as of Q1 2026.
  • Legal & General Group bought 206,414 Veracyte shares in Q1 2026, an estimated $7.64M.
  • Veracyte made up 0.01% of Legal & General Group's portfolio in Q1 2026, its #723 holding.
  • Legal & General Group first reported a position in Veracyte in Q4 2016 and has held it in 38 quarters since.
  • Legal & General Group's Veracyte position peaked at $29.1M in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.